Table 1.

Demographics and clinical characteristics of PD participants included in the primary analyses of the accelerometry data and the secondary analyses that included examination of muscle activity

	Primary Analyses n = 27	Secondary Analyses n = 15
Age (years)	70 (7) [51‐80]	70 (7) [51‐78]
Sex (male:female)	18:9	12:3
Handedness (left:right)	2:25	2:13
Most‐affected side (left:right)	14:13	10:5
Duration of disease (years)	12 (7) [1–26]	11 (7) [1–24]
H & Y30 , a	2.3 (0.7) [1–4]	2.3 (0.6) [1–4]
MDS‐UPDRS Part III motora
Total score	33 (14) [6–65]	33 (15) [7–65]
Rest tremorb (most‐affected hand)	1.9 (0.9) [1–4]	2.3 (0.8) [1–4]
Rest tremorb (least‐affected hand)	0.7 (1.0) [0–3]	0.7 (1.1) [0–3]
Constancy of rest tremorc	2.4 (1.2) [1–4]	2.9 (1.1) [1–4]
Time since medication (hours)	3.3 (1.3) [1.00–6.25]	3.5 (1.5) [1.75–6.25]

Data reported as mean (standard deviation) [min‐max].

^aScores obtained during the experimental session following tremor testing.

^bMDS‐UPDRS motor item 3.17.8

^cMDS‐UPDRS motor item 3.18.8